SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001328143-21-000033
Filing Date
2021-04-19
Accepted
2021-04-19 16:01:17
Documents
5
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A adms2021proxystatement.htm DEF 14A 468498
2 admsproxycard11.jpg GRAPHIC 75171
3 admsproxycard21.jpg GRAPHIC 59492
4 logo_grey1.jpg GRAPHIC 39819
5 mcfarlane_signature11.jpg GRAPHIC 10345
  Complete submission text file 0001328143-21-000033.txt   724379
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36399 | Film No.: 21834556
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences